Oxford Biomedica plc (LON:OXB)
London
· Delayed Price · Currency is GBP · Price in GBX 601.00
-11.00 (-1.80%)
Apr 28, 2026, 4:43 PM GMT
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 726.61 million as of April 28, 2026. Its market cap has increased by 145.70% in one year.
Market Cap
726.61M
Enterprise Value
777.84M
Revenue
168.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
601.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 726.61M, an increase of 4,077.45%. That is a compound annual growth rate of 13.93%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.11B |
| Genus | 1.61B |
| Avacta Group | 336.79M |
| PureTech Health | 298.43M |
| Scancell Holdings | 132.32M |
| Bioventix | 88.82M |
| Faron Pharmaceuticals Oy | 81.80M |
| 4basebio | 78.16M |